The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-(4-ethylphenyl)-N-isobutyl-3-(S-methylsulfonimidoyl)-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide ID: ALA4226421
Chembl Id: CHEMBL4226421
PubChem CID: 121429520
Max Phase: Preclinical
Molecular Formula: C25H36N2O5S2
Molecular Weight: 508.71
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCc1ccc(N(CC(C)C)S(=O)(=O)c2ccc(OCC3CCOCC3)c([S@](C)(=N)=O)c2)cc1
Standard InChI: InChI=1S/C25H36N2O5S2/c1-5-20-6-8-22(9-7-20)27(17-19(2)3)34(29,30)23-10-11-24(25(16-23)33(4,26)28)32-18-21-12-14-31-15-13-21/h6-11,16,19,21,26H,5,12-15,17-18H2,1-4H3/t33-/m1/s1
Standard InChI Key: OZSLLZRELNMFLA-MGBGTMOVSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 508.71Molecular Weight (Monoisotopic): 508.2066AlogP: 4.94#Rotatable Bonds: 10Polar Surface Area: 96.76Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 3.06CX LogP: 4.00CX LogD: 4.00Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.49Np Likeness Score: -1.27
References 1. Ouvry G, Bihl F, Bouix-Peter C, Christin O, Defoin-Platel C, Deret S, Feret C, Froude D, Hacini-Rachinel F, Harris CS, Hervouet C, Lafitte G, Luzy AP, Musicki B, Orfila D, Parnet V, Pascau C, Pascau J, Pierre R, Raffin C, Rossio P, Spiesse D, Taquet N, Thoreau E, Vatinel R, Vial E, Hennequin LF.. (2018) Sulfoximines as potent RORγ inverse agonists., 28 (8): [PMID:29571573 ] [10.1016/j.bmcl.2018.03.041 ]